SCHEMBL3437243

SCHEMBL3437243

CC[C@@H](OC(N)=O)[C@H](O)c1ccccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.45
AOC3 Q16853 1/20 0.41
ADRB2 P07550 2/20 0.38
ADRB1 P08588 2/20 0.38
CYP2D6 P10635 1/20 0.37
NFKB1 P19838 1/20 0.37
HIF1A Q16665 1/20 0.37
NISCH Q9Y2I1 1/20 0.36
BLM P54132 1/20 0.36
CXCL8 P10145 1/20 0.36
ALDH1A1 P00352 1/20 0.35
KCNQ2 O43526 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KMT2A Q03164 1/20 0.34
ATM Q13315 1/20 0.34
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34
IDO2 Q6ZQW0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3434095 1.00 CASP1 (0.45) CASP1AOC3ADRB2ADRB1CYP2D6
SCHEMBL3437161 1.00 CASP1 (0.45) CASP1AOC3ADRB2ADRB1CYP2D6
SCHEMBL23347641 1.00 CASP1 (0.45) CASP1AOC3ADRB2ADRB1CYP2D6
SCHEMBL15078242 0.89 CYP1A2 (0.41) CASP1AOC3CYP2D6NFKB1HIF1A
SCHEMBL10119422 0.86 CASP1 (0.41) CASP1AOC3ADRB2ADRB1CYP2D6
SCHEMBL3434882 0.86 CASP1 (0.41) CASP1AOC3ADRB2ADRB1CYP2D6
SCHEMBL18568026 0.86 CASP1 (0.41) CASP1AOC3ADRB2ADRB1CYP2D6
SCHEMBL3434560 0.86 CASP1 (0.41) CASP1AOC3ADRB2ADRB1CYP2D6
SCHEMBL15078572 0.85 CASP1 (0.42) CASP1AOC3ADRB2ADRB1NISCH
SCHEMBL23347543 0.85 ALDH1A1 (0.42) CASP1ALDH1A1L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968211-B1 PHENYL ALKYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILEPSY OR EPILEPSY-RELATED SYNDROME BIO PHARM SOLUTIONS CO LTD (KR) 2021-05-12 EP disclosed
US-10525030-B2 Phenyl carbamate compound and a composition for neuroprotection comprising the same BIO-PHARM SOLUTIONS CO., LTD. (KR) 2020-01-07 US disclosed
US-9956197-B2 Phenyl carbamate compounds for use in preventing or treating pediatric epilepsy and epilepsy-related syndromes BIO-PHARM SOLUTIONS CO., LTD. (KR) 2018-05-01 US disclosed
US-9956197-B2 Phenyl carbamate compounds for use in preventing or treating pediatric epilepsy and epilepsy-related syndromes BIO-PHARM SOLUTIONS CO., LTD. (KR) 2018-05-01 US disclosed
US-9907776-B2 Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same BIO-PHARM SOLUTIONS, CO., LTD. (KR) 2018-03-06 US disclosed
US-9907776-B2 Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same BIO-PHARM SOLUTIONS, CO., LTD. (KR) 2018-03-06 US disclosed
US-9872847-B2 Phenyl carbamate compounds for use in preventing or treating a movement disorder BIO-PHARM SOLUTIONS CO., LTD. (KR) 2018-01-23 US disclosed
US-9872847-B2 Phenyl carbamate compounds for use in preventing or treating a movement disorder BIO-PHARM SOLUTIONS CO., LTD. (KR) 2018-01-23 US disclosed
EP-2527314-B1 Process for preparation of phenyl carbamate derivatives BIO-PHARM SOLUTIONS CO LTD (KR) 2017-10-04 EP disclosed
EP-2797878-B1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING STROKE BIO-PHARM SOLUTIONS CO LTD (KR) 2017-08-16 EP disclosed
US-20130165408-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILESY BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-06-27 US disclosed
US-20130165409-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN ALLEVIATING OR TREATING PAIN BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-06-27 US disclosed
US-20130165410-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING STROKE BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-06-27 US disclosed
US-20130165509-A1 PHENYL ALKYL CARBAMATE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-06-27 US disclosed
US-20130005801-A1 PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-01-03 US disclosed
US-20130005801-A1 PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-01-03 US disclosed
US-20120184762-A1 PROCESS FOR PREPARATION OF PHENYL CARBAMATE DERIVATIVES BIO-PHARM SOLUTIONS CO., LTD. (KR) 2012-07-19 US disclosed
US-20120184762-A1 PROCESS FOR PREPARATION OF PHENYL CARBAMATE DERIVATIVES BIO-PHARM SOLUTIONS CO., LTD. (KR) 2012-07-19 US disclosed
WO-2012096458-A2 PROCESS FOR PREPARATION OF PHENYL CARBAMATE DERIVATIVES BIO-PHARM SOLUTIONS CO., LTD. (KR) 2012-07-19 WO disclosed
WO-2012002773-A2 PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME BIO-PHARM SOLUTIONS CO., LTD. (KR) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165408-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILESY CHAT, BCHE, GABBR1 CASP1 411/4885AOC3 1422/4885ADRB2 3907/4885
US-20130165409-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN ALLEVIATING OR TREATING PAIN ACHE, HDAC3, TRPV1 CASP1 459/4885AOC3 3285/4885ADRB2 3081/4885
US-20130005801-A1 PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME CPT1B, MYLK, PYGM CASP1 1756/4885AOC3 3242/4885ADRB2 183/4885
US-10525030-B2 Phenyl carbamate compound and a composition for neuroprotection comprising the same CHAT, BAX, CASP3 CASP1 24/4885AOC3 887/4885ADRB2 3595/4885
US-20130165509-A1 PHENYL ALKYL CARBAMATE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME MYLK, PDE3A, TNNC1 CASP1 2375/4885AOC3 3584/4885ADRB2 864/4885
US-20130165410-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING STROKE CPS1, PROC, DPP7 CASP1 276/4885AOC3 1313/4885ADRB2 4351/4885
US-20120184762-A1 PROCESS FOR PREPARATION OF PHENYL CARBAMATE DERIVATIVES CPS1, BCHE, ACHE CASP1 643/4885AOC3 1076/4885ADRB2 4106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.